Skip to main content
Clinical Trials/JPRN-UMIN000044489
JPRN-UMIN000044489Completed未知

Investigation on possible down-regulation of adverse effects of SARS-CoV-2 vaccination by type 2 allergic diseases using questionnaire to vaccine recipients - Investigation on possible down-regulation of adverse effects of SARS-CoV-2 vaccination by type 2 allergic diseases using questionnaire to vaccine recipients

Allergic Disease Research Center, Chutoen General Medical Center0 sites955 target enrollmentStarted: June 11, 2021Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
955

Study Overview

Brief Summary

For the systemic reactions, fatigability after the first dose tended to be more severe in the bronchial asthma than in the non-allergic group. Headache, joint pain, and fever tended to be more severe in the food allergy than in the non-allergic group after the second dose. For the local skin reactions, atopic dermatitis subjects tended to show rather less severe local skin reactions after the second dose.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18years-old to 100years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Apparent loss or mistake in the questionnaire sheet.

Investigators

Sponsor
Allergic Disease Research Center, Chutoen General Medical Center

Similar Trials